Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

HOWARU® Protect Adults

HOWARU Products, athletic woman climb satires to excise

HOWARU® Protect Adults

HOWARU® Protect Adults

The study published in Clinical Nutrition demonstrated that HOWARU® Protect Adults (Bifidobacterium lactis Bl-04®) appears to be a useful nutritional supplement in reducing the risk of URTI in healthy and physically-active adults.

A double-blind, randomized placebo-controlled trial was conducted in Australia by the Griffith Health Institute at Griffith University and the Australian Institute of Sport. Four hundred and sixty five participants (241 males; age 35 ± 12 y (mean ± SD) and 224 females; age 36 ± 12 y) were assigned to 1 of 3 groups: Group 1 – Bifidobacterium animalis subsp. lactis Bl-04® (Bl-04®) 2.0 × 109colony forming units per day, CFU per day, Group 2 – Lactobacillus acidophilus NCFM® and Bifidobacterium animalis subsp. lactis Bi-07 (NCFM® & Bi-07) 5 × 109 CFU each per day) or Group 3 – placebo mixed in a drink.

Results show that the risk of an upper respiratory illness episode was significantly lower in the Bl-04® group (hazard ratio 0.73; 95% confidence interval 0.55–0.95; P = 0.022) compared to placebo. There was no significant difference in the risk of illness between the NCFM® & Bi-07 group (hazard ratio 0.81; 0.62–1.08; P = 0.15) and the placebo group. There was a 0.7 and 0.9 month delay in the median time to an illness episode in the Bl-04® and NCFM® & Bi-07 groups, respectively, compared to placebo (placebo 2.5 months; Bl-04® 3.2 months; NCFM® & Bi-07 3.4 months).

Bar chart of HOWARU Protect adult reduce risk of respiratory tract infection associated symptoms
the bar chart of HOWARU Protect Adult Product at reduces risk of respiratory tract infection associated symptoms
HWOARU protect adult bar chart about experiencing URTI illness epidsodes

Reference:

West et al., 2014. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin Nutr. 2014 Aug;33(4):58 1-7.
https://www.clinicalnutritionjournal.com/article/S0261-5614(13)00261-6/pdf